Abstract:
The invention provides polyurethane components and compositions capable of providing internal mold release properties in SRIM applications. The polyol composition of the invention has an isocyanate reactive polyol (A) having a number average molecular weight from 100 to about 10,000 and an effective amount of internal mold release composition (B) having a silicon-containing polymer (a) and an epoxidized ester (b). The invention further provides an SRIM polyurethane composition useful in the preparation of molded polyurethane articles having internal mold release properties, the composition comprising an isocyanate component (I) and the isocyanate reactive polyol composition (component (II)) disclosed above. In another aspect of the invention, the invention provides methods of using the claimed compositions as well as the rigid cellular polyurethane SRIM articles resulting from such processes.
Abstract:
Customizing virtual assets is disclosed, including: transforming each of a plurality of initially identical copies of a virtual asset or a portion thereof to isolate a feature of the virtual asset or portion thereof; and enabling the isolated feature to be changed by a user in at least one of the transformed copies. In some embodiments, customizing virtual assets includes: receiving a three-dimensional model associated with the virtual asset; receiving an indication to save a two-dimensional virtual asset based on the 3D model with a 2D image wrapped on it; and using the 3D model with the 2D image wrapped on it to generate the 2D virtual asset.
Abstract:
The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
Abstract:
In one embodiment, a minibody monomer that binds PSMA is provided. The minibody monomer is encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA, an artificial hinge sequence, and a human IgG CH3 sequence. In another embodiment, a CysDB monomer that binds PSMA is provided. The CysDB monomer may be encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA and a cysteine tail. In other embodiments, methods for diagnosing or treating a cancer associated with PSMA expression in a subject are provided.
Abstract:
A method of making a transgenic plant by transforming into a host plant a recombinant DNA construct that expresses in the transgenic plant a rice polypeptide and the transgenic plant thus produced.
Abstract:
The present invention provides a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding an ELNINI (comprising an ELNINI signature sequence) polypeptide. The present invention also provides plants having modulated expression of a nucleic acid encoding an ELNINI polypeptide, which plants have enhanced yield-related traits relative to control plants. The present invention also provides constructs comprising ELNINI-encoding nucleic acids, useful in performing the methods of the present invention.
Abstract:
The present invention sets forth a method and system for communicating with an external device through a processing unit in a graphics system of a computing device. In one embodiment, the method comprises allocating a first set of memory buffers having a first memory buffer and a second memory buffer in the graphics system based on an identification information of the external device, and invoking a first thread processor of the processing unit of the graphics system to perform services associated with a physical layer according to the identification information of the external device by storing a first data stream received from the external device through an I/O interface of the processing unit of the graphics system in the first memory buffer and retrieving a second data stream from the second memory buffer for transmission to the external device through the I/O interface.
Abstract:
The present invention provides processes for preparing freeze-dried platelets, freeze-dried platelets made by those processes, platelets reconstituted from those freeze-dried platelets, methods of using the platelets for therapeutic, diagnostic, and research purposes, and kits comprising the freeze-dried platelets.
Abstract:
Disclosed herein are fusion antibodies created to provide both an antigen-binding site that targets the CD4 receptor and an antigen-binding site that targets the HIV envelope. The fusion antibodies disclosed herein provide improved potency and breadth against HIV as compared to monospecific antibodies, and additionally provide high barrier against viral resistance. Also disclosed are pharmaceutical formulations and therapeutic methods utilizing such fusion proteins.
Abstract:
The invention relates to a securing system for a receiver tube in a hearing device. The object of the invention is to provide a securing system for the receiver tube in a hearing device, which reliably prevents the occurrence of disruptive acoustic feedback and does not require adhesive to secure the receiver tube. This object of the invention is achieved with a hearing device, in particular a BTE hearing device, in which a receiver facility is disposed, wherein the hearing device has a connector piece, which is connected to the receiver facility by way of a receiver tube, in order to conduct an acoustic signal or acoustic signals generated by the receiver facility to an acoustic output of the hearing device, with the receiver tube being provided with a connecting element, which connects the receiver tube and the connector piece to each other in an essentially acoustically sealed manner.